Status:

COMPLETED

Carfilzomib, Cyclophosphamide, Dexamethasone in Transplant Eligible Newly Diagnosed High-risk Multiple Myeloma

Lead Sponsor:

Singapore General Hospital

Conditions:

Multiple Myeloma

Eligibility:

All Genders

21-70 years

Phase:

PHASE2

Brief Summary

Patients with high risk multiple myeloma have shorter remission periods and reduced overall survival. Prognostic significance of minimal residual disease negative remission is being highlighted in man...

Detailed Description

Carfilzomib is administered over 30 minutes as an infusion. For cycle 1 only, Carfilzomib is administered at 20mg/m2 IV on days 1 and 2, followed by escalation to 36 mg/m2 on days 8,9,15 and 16 on a 2...

Eligibility Criteria

Inclusion

  • Newly diagnosed Multiple Myeloma AND Transplant eligible AND
  • High Risk as defined by:
  • International Staging System 3 OR
  • FISH abnormality of t(4,14), t(14;16), 17p deletion or 1q amp
  • Patients must have evaluable myeloma, with at least one of the following (Assessed within 28 days of commencing the study)
  • Serum M protein \>/= 0.5g/dL or
  • Urine M protein \>200mg/24hr
  • Serum free light chains \>100mg/mL (involved light chain) and abnormal k/l ratio
  • For IgA patients who have no other means of measurement of disease, sIgA level \>0.75g/dL

Exclusion

  • Relapsed Myeloma
  • Non transplant eligible patient.
  • IgM subtype Myeloma
  • POEMS syndrome
  • Amyloidosis
  • Waldenstroms Macroglobulinemia
  • Radiation therapy to an extended field involving a significant volume of bone marrow within 21 days of randomization (Limited site radiation allowed).

Key Trial Info

Start Date :

October 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2020

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT02217163

Start Date

October 1 2014

End Date

October 1 2020

Last Update

October 20 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

National University Hospital

Singapore, Singapore, 119074

2

Singapore General Hospital

Singapore, Singapore, 169608